CLOs on the Move

Chart SeQual Technologies Inc

www.sequal.com

 
SeQual is committed to a program of continual improvement and expansion of its air separation product line. We constantly strive to identify new opportunities for on-site gas separation that will benefit our customers by improving or cost-reducing their
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Great Lakes Medical Supply

Great Lakes Medical Supply is a Warren, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Certol International

Certol International is a Commerce City, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroOptx

MicroOptx is an early stage medical device company that is building a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye. Our mission is to change the way the World treats glaucoma – halting the devastating effects of this progressive disease. MicroOptx is led by recognized medical, industry and financial veterans who are dedicated towards preventing blindness.

Gnathos Dental Products

Gnathos Dental Products is a Union, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack